11.04
price up icon0.82%   0.09
after-market After Hours: 11.04
loading
Exagen Inc stock is traded at $11.04, with a volume of 219.10K. It is up +0.82% in the last 24 hours and up +13.35% over the past month. Exagen Inc is a commercial-stage diagnostics company committed to addressing the unmet need for the accurate diagnosis and monitoring of patients affected by autoimmune rheumatic diseases. It currently markets ten testing products under its Avise brand to provide an accurate, timely, and differential diagnosis and to optimize the treatment of ARDs. It markets and sells solutions to community rheumatologists.
See More
Previous Close:
$10.95
Open:
$11
24h Volume:
219.10K
Relative Volume:
0.79
Market Cap:
$242.92M
Revenue:
$52.55M
Net Income/Loss:
$-23.69M
P/E Ratio:
-11.74
EPS:
-0.94
Net Cash Flow:
$-15.29M
1W Performance:
+1.28%
1M Performance:
+13.35%
6M Performance:
+159.15%
1Y Performance:
+316.60%
1-Day Range:
Value
$10.78
$11.06
1-Week Range:
Value
$10.62
$11.28
52-Week Range:
Value
$2.38
$11.28

Exagen Inc Stock (XGN) Company Profile

Name
Name
Exagen Inc
Name
Phone
(760) 560-1501
Name
Address
1261 LIBERTY WAY, VISTA, CA
Name
Employee
209
Name
Twitter
@ExagenInc
Name
Next Earnings Date
2025-03-11
Name
Latest SEC Filings
Name
XGN's Discussions on Twitter

Compare XGN with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Diagnostics & Research icon
XGN
Exagen Inc
11.04 240.94M 52.55M -23.69M -15.29M -0.94
Diagnostics & Research icon
TMO
Thermo Fisher Scientific Inc
524.58 198.17B 43.21B 6.58B 6.17B 17.28
Diagnostics & Research icon
DHR
Danaher Corp
205.14 144.97B 24.01B 3.41B 4.86B 4.7082
Diagnostics & Research icon
IDXX
Idexx Laboratories Inc
633.32 49.29B 4.04B 985.66M 774.34M 12.01
Diagnostics & Research icon
A
Agilent Technologies Inc
138.23 38.73B 6.79B 1.22B 1.09B 4.2644
Diagnostics & Research icon
IQV
Iqvia Holdings Inc
203.77 33.69B 15.70B 1.24B 2.01B 6.9036

Exagen Inc Stock (XGN) Upgrades & Downgrades

Date Action Analyst Rating Change
Sep-11-25 Initiated B. Riley Securities Buy
Jul-30-25 Upgrade KeyBanc Capital Markets Sector Weight → Overweight
Jul-23-25 Initiated Craig Hallum Buy
Aug-05-22 Downgrade KeyBanc Capital Markets Overweight → Sector Weight
Oct-15-21 Resumed Cowen Outperform
Apr-15-21 Initiated Canaccord Genuity Buy
Nov-10-20 Initiated KeyBanc Capital Markets Overweight
Oct-08-20 Initiated BTIG Research Buy
Jun-02-20 Resumed Cantor Fitzgerald Overweight
Oct-14-19 Initiated Cantor Fitzgerald Overweight
Oct-14-19 Initiated Cowen Outperform
Oct-14-19 Initiated William Blair Outperform
View All

Exagen Inc Stock (XGN) Latest News

pulisher
11:10 AM

Detecting support and resistance levels for Exagen Inc.July 2025 Levels & Real-Time Stock Movement Alerts - newser.com

11:10 AM
pulisher
11:00 AM

How to build a custom watchlist for Exagen Inc.Buy Signal & Accurate Entry and Exit Point Alerts - newser.com

11:00 AM
pulisher
10:04 AM

Should you hold or exit Exagen Inc. nowJuly 2025 Trade Ideas & Real-Time Volume Trigger Notifications - newser.com

10:04 AM
pulisher
08:32 AM

Has Exagen Inc. formed a bullish divergenceTrade Performance Summary & Growth Focused Stock Pick Reports - newser.com

08:32 AM
pulisher
08:30 AM

Analyzing Exagen Inc. with multi timeframe chartsMarket Sentiment Summary & Smart Investment Allocation Tips - newser.com

08:30 AM
pulisher
08:09 AM

What to do if you’re stuck in Exagen Inc.Watch List & Verified Technical Trade Signals - newser.com

08:09 AM
pulisher
08:08 AM

Earnings visualization tools for Exagen Inc.Market Risk Analysis & High Return Stock Watch Alerts - newser.com

08:08 AM
pulisher
05:40 AM

Custom strategy builders for tracking Exagen Inc.Trade Exit Summary & Daily Technical Stock Forecast Reports - newser.com

05:40 AM
pulisher
04:53 AM

Will Exagen Inc. stock maintain momentum in 20252025 Market Sentiment & Safe Entry Zone Tips - newser.com

04:53 AM
pulisher
03:43 AM

Will Exagen Inc. benefit from macro trendsJuly 2025 Selloffs & Low Drawdown Investment Strategies - newser.com

03:43 AM
pulisher
Oct 12, 2025

Is Exagen Inc. (E08A) stock testing key supportJuly 2025 Levels & Real-Time Chart Breakout Alerts - newser.com

Oct 12, 2025
pulisher
Oct 11, 2025

Exagen’s (XGN) “Sell (D-)” Rating Reiterated at Weiss Ratings - Defense World

Oct 11, 2025
pulisher
Oct 10, 2025

Is Exagen Inc. stock ready for a breakoutInflation Watch & Weekly Stock Breakout Alerts - newser.com

Oct 10, 2025
pulisher
Oct 09, 2025

Does Exagen Inc. show high probability of reboundNew Guidance & Safe Entry Point Alerts - newser.com

Oct 09, 2025
pulisher
Oct 08, 2025

Exagen (NASDAQ:XGN) Earns Sell (D-) Rating from Weiss Ratings - MarketBeat

Oct 08, 2025
pulisher
Oct 07, 2025

What analysts say about Exagen Inc stockMoving Average Crossovers & Affordable Investment Tips - earlytimes.in

Oct 07, 2025
pulisher
Oct 06, 2025

How Exagen Inc. stock compares to market leadersQuarterly Trade Summary & Real-Time Volume Surge Alerts - newser.com

Oct 06, 2025
pulisher
Oct 06, 2025

Can Exagen Inc. recover in the next quarterBond Market & Weekly Momentum Stock Picks - newser.com

Oct 06, 2025
pulisher
Oct 06, 2025

Exagen Inc. (NASDAQ:XGN) Given Average Recommendation of "Moderate Buy" by Analysts - MarketBeat

Oct 06, 2025
pulisher
Oct 06, 2025

Exagen Inc. recovery potential after sell offBond Market & Reliable Price Breakout Signals - newser.com

Oct 06, 2025
pulisher
Oct 04, 2025

Exagen Inc Stock Analysis and ForecastBullish Engulfing Patterns & Small Budget Capital Investment - earlytimes.in

Oct 04, 2025
pulisher
Oct 03, 2025

Exagen Inc. (XGN) Reports Q1 Loss, Tops Revenue Estimates - MSN

Oct 03, 2025
pulisher
Oct 03, 2025

Is Exagen Inc. stock a bargain at current levelsQuarterly Investment Review & Real-Time Volume Spike Alerts - newser.com

Oct 03, 2025
pulisher
Oct 03, 2025

Will Exagen Inc. (E08A) stock recover faster than industryMarket Sentiment Review & Real-Time Volume Trigger Notifications - newser.com

Oct 03, 2025
pulisher
Oct 03, 2025

Is Exagen Inc. (E08A) stock supported by free cash flowJuly 2025 Levels & Technical Buy Zone Confirmations - newser.com

Oct 03, 2025
pulisher
Oct 02, 2025

What drives Exagen Inc stock priceUtilities Sector Analysis & Crush the Market with Breakout Winners - earlytimes.in

Oct 02, 2025
pulisher
Oct 02, 2025

With 38% stake, Exagen Inc. (NASDAQ:XGN) seems to have captured institutional investors' interest - Yahoo Finance

Oct 02, 2025
pulisher
Sep 30, 2025

Can Exagen Inc. (E08A) stock test all time highs2025 Growth vs Value & Reliable Breakout Forecasts - newser.com

Sep 30, 2025
pulisher
Sep 29, 2025

Institutional investors have a lot riding on Exagen Inc. (NASDAQ:XGN) with 38% ownership - simplywall.st

Sep 29, 2025
pulisher
Sep 29, 2025

Exagen, Inc. Hits New 52-Week High of $11.09, Surging 447% - Markets Mojo

Sep 29, 2025

Exagen Inc Stock (XGN) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading

Exagen Inc Stock (XGN) Insider Trading

Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total
NMSIC Co-Investment Fund, L.P.
10% Owner
Mar 25 '25
Sale
3.30
350,000
1,155,000
1,758,958
NMSIC Co-Investment Fund, L.P.
10% Owner
Nov 20 '24
Sale
3.30
200,000
660,040
2,108,958
Black Jeffrey G.
Chief Financial Officer
Nov 15 '24
Buy
2.98
22,298
66,448
274,492
ABALLI JOHN
President and CEO
Nov 14 '24
Buy
2.81
24,305
68,297
689,799
diagnostics_research WAT
$336.33
price up icon 1.61%
diagnostics_research DGX
$182.78
price down icon 0.70%
diagnostics_research LH
$276.64
price down icon 0.45%
$174.17
price up icon 2.89%
diagnostics_research MTD
$1,284.74
price up icon 0.87%
diagnostics_research IQV
$203.77
price up icon 2.83%
Cap:     |  Volume (24h):